Merck, Lilly and Celgene have all invested heavily in technologies or companies that enable or are directly engaged in stem cell research. None of the projects are turning a profit or will likely do so for years. If Pelosi's Part D plan is implemented....slashing prices and profits of today's drugs by 40 percent with more of the same for stem cell cures in the future along with
new hurdles including comparative effectiveneess studies that take years to compelte and mandatory delays of at least a year (that's the VA anyway) in even allowing something to be used off formulary...what will happen?
Oh, and let's not forget the safety requirements that add at least two years to the time it takes to get such cures to dying patients.
Great assurances of safety in the Post-Pelosi/Waxman world means more and longer clinical trials instead of personalized medicine.
Well, the D's said they didn't want the status quo.
new hurdles including comparative effectiveneess studies that take years to compelte and mandatory delays of at least a year (that's the VA anyway) in even allowing something to be used off formulary...what will happen?
Oh, and let's not forget the safety requirements that add at least two years to the time it takes to get such cures to dying patients.
Great assurances of safety in the Post-Pelosi/Waxman world means more and longer clinical trials instead of personalized medicine.
Well, the D's said they didn't want the status quo.
